|
US4661499A
(en)
*
|
1985-06-18 |
1987-04-28 |
Merck Frosst Canada, Inc. |
2-[(substituted)-phenoxymethyl]quinolines
|
|
GB9122590D0
(en)
*
|
1991-10-24 |
1991-12-04 |
Lilly Industries Ltd |
Pharmaceutical compounds
|
|
WO1994006802A1
(fr)
|
1992-09-18 |
1994-03-31 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Compose de thienodiazepine et son utilisation medicinale
|
|
ES2062943B1
(es)
*
|
1993-03-23 |
1995-11-16 |
Uriach & Cia Sa J |
Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas.
|
|
US5486612A
(en)
|
1993-12-14 |
1996-01-23 |
Eli Lilly And Company |
N-benzyl dihydroindole LTD4 antagonists
|
|
FR2734265B1
(fr)
*
|
1995-05-17 |
1997-06-13 |
Adir |
Nouveaux composes spiro heterocycliques, leur procede de preparation et les compositions pharmaceutiques les contenant
|
|
US5783586A
(en)
|
1996-10-01 |
1998-07-21 |
Abbott Laboratories |
Heteroarylmethoxyphenylthioalkyl carboxylates as inhibitors of leukotriene biosynthesis
|
|
EP0968179B1
(en)
*
|
1997-02-25 |
2002-09-25 |
Syngenta Participations AG |
N-sulphonyl and n-sulphinyl amino acid amides as microbiocides
|
|
US6544979B1
(en)
|
1997-09-18 |
2003-04-08 |
Janssen Pharmaceuticals, N.V. |
Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents
|
|
DE10007203A1
(de)
|
2000-02-17 |
2001-08-23 |
Asta Medica Ag |
Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
|
|
HUP0301501A2
(hu)
|
2000-06-23 |
2003-08-28 |
Novo Nordisk A/S |
Glükagon antaagonista/inverz agonista vegyületek, ezeket tartalmazó gyógyászati készítmények, valamint a vegyületek alkalmazása gyógyászati készítmények előállítására
|
|
WO2002040445A1
(en)
|
2000-11-17 |
2002-05-23 |
Novo Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
US20030203946A1
(en)
|
2000-11-17 |
2003-10-30 |
Carsten Behrens |
Glucagon antagonists/inverse agonists
|
|
WO2003061567A2
(en)
*
|
2002-01-18 |
2003-07-31 |
Merck & Co., Inc. |
Selective s1p1/edg1 receptor agonists
|
|
WO2004063147A1
(en)
|
2003-01-10 |
2004-07-29 |
Novo Nordisk A/S |
Salts and solvates of glucagon antagonists
|
|
US7329682B2
(en)
|
2003-04-03 |
2008-02-12 |
Ewha University-Industry Collaboration Foundation |
Method for inhibiting 5-lipoxygenase using a benzoxazole derivative
|
|
ATE403654T1
(de)
*
|
2003-07-28 |
2008-08-15 |
Janssen Pharmaceutica Nv |
Benzimidazol-, benzothiazol- und benzoxazolderivate und deren verwendung als lta4h-modulatoren
|
|
KR100896380B1
(ko)
*
|
2005-01-07 |
2009-05-08 |
화이자 프로덕츠 인코포레이티드 |
헤테로방향족 퀴놀린 화합물 및 ｐｄｅ10 저해제로서의그의 용도
|
|
US20090126806A1
(en)
|
2005-03-08 |
2009-05-21 |
Hamza Hassan H |
Adjustable vacuum relief safety valve system for swimming pools and spas
|
|
CA2603122A1
(en)
|
2005-03-31 |
2006-10-05 |
Janssen Pharmaceutica N.V. |
Phenyl and pyridyl lta4h modulators
|
|
TWI387592B
(zh)
|
2005-08-30 |
2013-03-01 |
Novartis Ag |
經取代之苯并咪唑及其作為與腫瘤形成相關激酶之抑制劑之方法
|
|
WO2007047397A2
(en)
*
|
2005-10-13 |
2007-04-26 |
Smithkline Beecham Corporation |
Phenol ethers as modulators of the opioid receptors
|
|
DE102006021878A1
(de)
|
2006-05-11 |
2007-11-15 |
Sanofi-Aventis |
Phenylamino-benzoxazol substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
WO2008057280A1
(en)
|
2006-10-27 |
2008-05-15 |
Amgen Inc. |
Multi-cyclic compounds and methods of use
|
|
TW200906396A
(en)
|
2007-02-14 |
2009-02-16 |
Janssen Pharmaceutica Nv |
LTA4H modulators and uses thereof
|
|
BRPI0811097A2
(pt)
|
2007-05-23 |
2014-12-09 |
Novartis Ag |
Inibidores de raf para o tratamento de câncer de tireoide
|
|
AR069126A1
(es)
|
2007-10-31 |
2009-12-30 |
Janssen Pharmaceutica Nv |
Diaminas en puente o fusionadas sustituidas con arilo como moduladores de leucotrieno a4 hidrolasa
|
|
US9446995B2
(en)
|
2012-05-21 |
2016-09-20 |
Illinois Institute Of Technology |
Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
|
|
MY157597A
(en)
|
2008-04-11 |
2016-06-30 |
Janssen Pharmaceutica Nv |
Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene a4 hydrolase
|
|
EP2274288A2
(en)
*
|
2008-04-24 |
2011-01-19 |
Incyte Corporation |
Macrocyclic compounds and their use as kinase inhibitors
|
|
KR20110025827A
(ko)
|
2008-06-13 |
2011-03-11 |
노파르티스 아게 |
신경섬유종증을 위한 치환된 벤즈이미다졸
|
|
US20100041891A1
(en)
|
2008-08-12 |
2010-02-18 |
Takeda Pharmaceutical Company Limited |
Amide compound
|
|
PL2391366T3
(pl)
|
2009-01-29 |
2013-04-30 |
Novartis Ag |
Podstawione benzimidazole do leczenia gwiaździaków
|
|
EP2921480B1
(en)
|
2012-11-19 |
2017-10-11 |
Takeda Pharmaceutical Company Limited |
Nitrogen-containing heterocyclic compound
|
|
PT2958913T
(pt)
|
2013-02-20 |
2018-12-03 |
Lg Chemical Ltd |
Agonistas de recetores de esfingosina-1-fosfato, métodos para a sua preparação e composições farmacêuticas que os contêm como agente ativo
|
|
CN104045552B
(zh)
|
2013-03-13 |
2019-06-11 |
江苏先声药业有限公司 |
作为神经保护剂的药用化合物
|
|
EP2994140A4
(en)
|
2013-05-07 |
2017-05-03 |
Inhibikase Therapeutics, Inc. |
Methods for treating hcv infection
|
|
HK1219737A1
(zh)
|
2013-06-10 |
2017-04-13 |
Bayer Pharma Aktiengesellschaft |
用於治疗癌症的新化合物
|
|
US9452986B2
(en)
|
2014-02-06 |
2016-09-27 |
Abbvie Inc. |
6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use
|
|
ES2864079T3
(es)
|
2014-05-30 |
2021-10-13 |
Pfizer |
Derivados de carbonitrilo como moduladores selectivos del receptor de andrógenos
|
|
US10570136B2
(en)
|
2015-07-28 |
2020-02-25 |
Udc Ireland Limited |
Process for the preparation of benzimidazo[1,2-a] benzimidazoles
|
|
EP3659597A3
(en)
|
2015-08-26 |
2020-09-09 |
The Texas A&M University System |
Compositions and methods for drug sensitization of parasites
|
|
AR111495A1
(es)
|
2017-05-01 |
2019-07-17 |
Theravance Biopharma R&D Ip Llc |
Compuestos de imidazo-piperidina fusionada como inhibidores de jak
|
|
CN107383014B
(zh)
|
2017-06-21 |
2019-04-30 |
南方医科大学 |
一种1H-吡唑并[3,4-d]嘧啶类化合物及其制备方法和应用
|
|
CN113784713A
(zh)
*
|
2019-01-11 |
2021-12-10 |
纳吉斯制药股份有限公司 |
白三烯合成抑制剂
|